InsiderDB
Sign inStart free trial

Solventum (SOLV)

Healthcare · Medical - Instruments & Supplies

7 members of Congress have disclosed 7 trades in Solventum (SOLV) since 2024: 1 buy and 6 sales. The most recent was disclosed on Jul 21, 2026. 1 trade was made by members of a committee that oversees Solventum's industry.

Trades disclosed
7
Members trading
7
Buys / sells
1 / 6
Reported value
$21K–$140K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow SOLV

What else is happening at SOLV

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. SOLVLobbying report·Lobbying disclosures

    SOLV: third_quarter 2026 lobbying report

    -Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and

    Public: Oct 20, 2026, 10:48 PM EDTOriginal source ↗
  2. SOLVLobbying report·Lobbying disclosures

    SOLV: third_quarter 2026 lobbying report

    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development. Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.

    Public: Oct 19, 2026, 7:42 PM EDTOriginal source ↗
  3. SOLVLobbying report·Lobbying disclosures

    SOLV: second_quarter 2026 lobbying report

    -Issues related to Department of Defense policy, procurement, and contracting processes for medical technology. -Issues related to H.R. 1 implementation (One Big Beautiful Bill). -Issues related to domestic and global medical supply chain resilience. -Tariff issues generally. -Issues related to the 232 investigation of imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices. -Issues related to Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure to Impose and Effectively Enforce a Prohibition on

    Public: Jul 20, 2026, 9:15 PM EDTOriginal source ↗
  4. SOLVLobbying report·Lobbying disclosures

    SOLV: second_quarter 2026 lobbying report

    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development. Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.

    Public: Jul 18, 2026, 2:26 PM EDTOriginal source ↗

Committee overlaps

Trades by members of a committee that oversees Solventum's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded SOLV

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.